The activation of this pathway by DVL3 was shown to upregulate stemness markers and enhance the mesenchymal phenotype, reinforcing the idea that DVL3 supports CRC progression through regulation of CSC properties and EMT. The gene discussed is DVL3; the disease is colorectal carcinoma.